Novel vaccine lowers LDL cholesterol independent of statins
The effectiveness of virus-like particle (VLP)-based vaccines targeting epitopes in the low-density lipoprotein (LDL) receptor.
Long COVID unmasked: Patients share varied physical, mental, and social challenges
Patient experiences of the post-acute sequelae of coronavirus disease 2019 (COVID-19) or long COVID.
Preterm birth risk highlighted in Stanford-led study on sleep and activity during pregnancy
Researchers developed series2signal, a novel, state-of-the-art prediction model that used wearable data from pregnant women to predict gestational age as a proxy for the progression of pregnancy and the likelihood of poor…
Berlin-Based Lab Instruments Company Knauer Tackles Sustainability
At the same time as the UN Sustainability Summit in New York, laboratory measuring instrument manufacturer KNAUER launched this year's Sustainability Week on September 18, 2023.
Evonetix unveils new branding to align with its vision for gene-length DNA synthesis
EVONETIX LTD (‘Evonetix’) today announces the introduction of new branding.
Start Codon invites life sciences leaders, founders, and investors to Innovation Showcase 2023
Start Codon is pleased to invite life sciences people from across the life science and biotech industries to attend their Innovation Showcase 2023.
A better method to predict polygenic inheritance across multiple ancestries
Researchers report the results obtained from the use of a new PRS calculator called CT-SLEB on a multi-national GWAS database.
Benefits of postpartum dietary intervention on weight management in obese women
Researchers explore the effects of a dietary intervention in postpartum women with higher body mass index.
Applied Cells opens CellQuest Research Grant to accelerate cutting-edge multiple myeloma research
Applied Cells is thrilled to announce the opening of the CellQuestGrant.
Mogrify extends Series A financing to $46 million USD
Mogrify Limited (Mogrify®), a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced today an additional $10 million USD closing of its…